Literature DB >> 6205324

Human glioma associated and related antigens, identified by monoclonal antibodies.

J Yoshida, N Kageyama, R Ueda, T Takahashi.   

Abstract

Tumour specific and various tumour-associated antigens expressed on human glioma cells were reported from many laboratories. These have been identified by xeno-, allo-, or auto-sera and more recently by utilizing monoclonal antibodies produced by hybridoma technique. In this article, the results of reports are summarized comparing the studies with conventional antisera and monoclonal antibodies. The present and future clinical applications of these monoclonal antibodies are described.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6205324     DOI: 10.1007/bf01743287

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  37 in total

1.  CHROMATOGRAPHIC AND ELECTROPHORETIC FRACTIONATION OF SOLUBLE PROTEINS OF BRAIN AND LIVER.

Authors:  B W MOORE; D MCGREGOR
Journal:  J Biol Chem       Date:  1965-04       Impact factor: 5.157

2.  Localization of the glial fibrillary acidic protein in astrocytes by immunofluorescence.

Authors:  A Bignami; L F Eng; D Dahl; C T Uyeda
Journal:  Brain Res       Date:  1972-08-25       Impact factor: 3.252

3.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

4.  Expression of human fetal brain antigens by human tumors of neuroectodermal origin as defined by monoclonal antibodies.

Authors:  C J Wikstrand; D D Bigner
Journal:  Cancer Res       Date:  1982-01       Impact factor: 12.701

5.  Shared antigenic determinants between human brain and human T-cell line.

Authors:  A Takada; Y Takada; U Ito; J Minowada
Journal:  Clin Exp Immunol       Date:  1974-12       Impact factor: 4.330

6.  Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies.

Authors:  M Herlyn; Z Steplewski; D Herlyn; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

7.  Common antigenic determinants on human melanoma, glioma, neuroblastoma, and sarcoma cells defined with monoclonal antibodies.

Authors:  R C Seeger; H M Rosenblatt; K Imai; S Ferrone
Journal:  Cancer Res       Date:  1981-07       Impact factor: 12.701

8.  Hybrid myelomas producing antibodies against a human neuroblastoma antigen present on fetal brain.

Authors:  R H Kennett; F Gilbert
Journal:  Science       Date:  1979-03-16       Impact factor: 47.728

9.  A monoclonal antibody identifying a cell surface antigen shared by common acute lymphoblastic leukemias and B lineage cells.

Authors:  M F Greaves; W Verbi; J Kemshead; R Kennett
Journal:  Blood       Date:  1980-12       Impact factor: 22.113

10.  Specific immunoreactivity of hybridoma-secreted monoclonal anti-melanoma antibodies to cultured cells and freshly derived human cells.

Authors:  M Herlyn; W H Clark; M J Mastrangelo; D P Guerry; D E Elder; D LaRossa; R Hamilton; E Bondi; R Tuthill; Z Steplewski; H Koprowski
Journal:  Cancer Res       Date:  1980-10       Impact factor: 12.701

View more
  3 in total

1.  Radioimmunoassay of glioma-associated antigen in cerebrospinal fluid and its usefulness for the diagnosis and monitoring of human glioma.

Authors:  J Yoshida; R Yamamoto; T Wakabayashi; M Nagata; H Seo
Journal:  J Neurooncol       Date:  1990-02       Impact factor: 4.130

2.  Radioimaging of human glioma xenografts with 123I labeled monoclonal antibody G-22 against glioma-associated antigen.

Authors:  J Yoshida; M Mizuno; I Inoue; T Wakabayasi; K Sugita; H Seo; K Chiba
Journal:  J Neurooncol       Date:  1990-06       Impact factor: 4.130

3.  Monoclonal antibody against ependymoma-derived cell line.

Authors:  Y Mihara; Y Matsukado; S Goto; Y Ushio; S Tokumitsu; K Takahashi
Journal:  J Neurooncol       Date:  1992-01       Impact factor: 4.130

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.